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Abstract
The Caco-2 cell line is one of themost important in vitromodels for enterocytes, and is used to study drug
absorptionanddisease, including inflammatoryboweldiseaseandcancer. Inorder touse themodeloptimal-
ly, it is necessary tomap its functional entities. In this study, we have generated genome-widemaps of active
transcription start sites (TSSs), and active enhancers in Caco-2 cells with or without tumour necrosis factor
(TNF)-a stimulation to mimic an inflammatory state. We found 520 promoters that significantly changed
their usage level uponTNF-a stimulation; of these, 52%arenot annotated.A subset of thesehas thepotential
to confer change in protein function due to protein domain exclusion. Moreover, we locate 890 transcribed
enhancer candidates, where ∼50% are changing in usage after TNF-a stimulation. These enhancers share
motif enrichments with similarly responding gene promoters. As a case example, we characterize an enhan-
cer regulating the laminin-5g2-chain (LAMC2) genebynuclear factor (NF)-kBbinding. This report is thefirst
topresent comprehensive TSS andenhancermapsoverCaco-2 cells, andhighlightsmanynovel inflammation-
specific promoters and enhancers.
Key words: alternative promoters; inflammation; non-coding RNAs; transcribed enhancers; transcriptional
regulation
1. Introduction
Intestinalepithelial cells (IECs)actasamucosalbarrier
between the luminal environment (i.e. microbes and
their toxins as well as food-derived antigens) and the in-
ternal milieu, and actively contribute to the gut immune
system.1 Maintenance of this barrier is crucial for the
homeostasis, i.e. the immune system’s ability to remain
tolerant to antigens. Therefore, dysregulation within
the epithelial layercan increase permeability, lead to ab-
normalities in interactions between IECs and immune
cells, and disturb the intestinal immune homeostasis,
all of which are linked to the clinical disease course of
several intestinal disorders including inflammatory
bowel disease (IBD).2 IBD is a chronic inflammation of
the intestine and is characterized by an imbalanced pro-
duction of a wide range of pro-inflammatory mediators
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including tumour necrosis factor (TNF)-a3. TNF-a is a
central pro-inflammatory cytokine in IBD and the use
of TNF-inhibitors in the treatment of IBD has been suc-
cessful.4 The Caco-2 cell line is a widely used model for
human IECs, resembling the in vivo differentiation of
enterocytes/colonocytesboth morphologicallyandbio-
chemically.5 Because of this, it is an important model for
molecular studies focused on gut disease including IBD.
At the same time, differentiated Caco-2 cells are widely
used to predict the absorption of orally administrated
drugs in the pharmaceutical industry.
Despite its wide usage in both applied and basic
science, there have been only few comprehensive
genome-wide efforts to characterize Caco-2 on the
transcriptional level. This is needed, because genome-
wide methods have shown that the majority of genes
have multiple isoforms, driven by alternative promoter
usage,6,7 alternative splicing,8 or alternative transcrip-
tion termination.9 Usage of alternative isoforms can
havedrastic functional impact, for instanceby lossof func-
tionalproteindomains.10 Microarray-basedmethodswill
fail topinpointtheexactpromotersthatarerespondingto
cellular changes, because most genes have alternative
promoters.6 Alternative promoters are often tissue- or
context-specific6 and can thereby be viewed as inde-
pendent regulatory platforms in which different cellu-
lar contexts can influence the expression of a gene. An
example of this is the DLGAP gene which has four alter-
native promoters, each specific for a different brain
tissue.10 Despite its importance, alternative promoter
usage is uncharacterized in most medically relevant
models.
State-of-the-art methods for the detection of active
promoters or transcription start sites (TSSs) are CAGE11
and TSS-seq.12 These methods are genome-wide and
basedongenerating full-length cDNAs frommRNAs, fol-
lowed by sequencing the first 20–40 nucleotides from
their 50-end. These techniques have been used to chart
mammaliangenomes,13,14dissectTSSusageincorepro-
moters, investigate evolutionary conservation and
turnover, and for systems biology of developing macro-
phages (reviewed in refs15,16). The CAGE technique has
been thoroughly validated by gene reporter assays,
histone marks and other RNA sequencing techniques
(e.g. refs6,10,14,17,18).
Surprisingly, the CAGE technique can also identify
active enhancers, since the active enhancers are lowly
transcribedinabidirectionalpattern.19Usingmassiveen-
hancer reporter screens,wehavepreviouslyshown19 that
this approach is more than two times as accurate as non-
transcribed enhancer candidates identified by histone
modification ChIP-seq or DHS-seq (e.g. refs20–22).
In this study, we present the first genome-wide map
of promoters for the Caco-2 cell line, before and after
stimulation with pro-inflammatory TNF-a. We show
that TNF-a stimulation induces expression from a
large number of promoters, where many are novel al-
ternative promoters of well-characterized genes and
some represent completely novel TNF-a-specific non-
protein-coding transcripts. Similarly, we identify many
candidate enhancer regions that respond to TNF-a
stimulation and can be linked with similarly responding
genes. Finally, we show that many TNF-a-responsive
promoters and enhancers are likely regulated by
known inflammatory factors like NF-kB.
2. Materials and methods
2.1. Cell culture and stimulation
Thehumanintestinalcell lineCaco-2(AmericanTissue
Type Culture Collection, Rockville, MD, USA) cells were
cultivated as monolayers and maintained as previously
described.23 For stimulation experiments, 106 cells
were seeded in 24-well plates (NUNC Brand, Thermo
Fisher, Rochester, NY, USA) and grown to .95% conflu-
ence. Cells were then stimulated in medium with or
without TNF-a (R&D Systems, Minneapolis, MN, USA) in
the presence or absence of tosyl phenylalanyl chloro-
methyl ketone (TPCK) NF-kB inhibitor; 100 mM; Sigma-
Aldrich, St. Louis, MO, USA), FR180204 (ERK inhibitor;
30 mM; Merck Chemicals, Darmstadt, Germany), or
vehicle [0.4% dimethyl sulphoxide (DMSO); Sigma-
Aldrich] as done previously.24 In experiments involving
treatment with inhibitors, cells were exposed to the
inhibitors 1 h prior to the addition of TNF-a and subse-
quently stimulated with TNF-a (10 nM) for 24 h. For
CAGE analysis, we used biological triplicates with or
without TNF-a (10 nM).
2.2. Protein extraction and immunoblotting
Protein extraction and immunoblotting was done as
described in Seidelin et al.,25 using LAMC2 (1 : 333;
mouse monoclonal, Millipore, Billerica, MA, USA) and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
antibodies (1 : 20,000; mouse monoclonal; Fitzgerald,
Concord, MA, USA).
2.3. CAGE library preparation and processing
CAGE libraries were prepared from 5 mg of total RNA
purified using the Purelink mini kit (Ambion, Austin, TX,
USA) as recommended by the manufacturer. Libraries
were prepared and mapped to the hg19 assembly as
in ref.19 CAGE tags that mapped close to each other
on the same strand were grouped into 52,451 tag clus-
ters (TCs)as in ref.26 Theexpression level foreach library
in each TC was normalized to sample size (tags per
million mapped tags, TPM). For differential expression
assessment, we used EdgeR27 on the TCs having
.4TPM and used an FDR threshold of ,0.05, compar-
ing TNF-a stimulation and control replicates. This
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defined a set of TCs that were induced by TNF-a [TNF-
a(þ)] and a set of TCs that are depleted [TNF-a (2)].
2.4. Gene ontology analysis
TNF-a(þ), TNF-a(2)and thesetof all TNF-aTCs with
TPM . 4 were intersected with RefSeq genes. Genes
with more than two TCs were counted only once.
DAVID28 was used to identify enriched gene ontology
(GO) terms, using default settings. The RefSeq gene
symbols were uploaded and converted to DAVID gene
symbols. For the TNF-a(þ) and TNF-a(2) sets, only
Homo sapiens annotations were used. All Caco-2 TCs
with TPM . 4 was used as background. Only overrepre-
sentations of GO terms, where P, 0.05 (Benjamini
corrected), were reported.
2.5. Enhancer detection, expression quantification
and promoter associations
Putative Caco-2 enhancers were identified from
CAGE-derived bidirectionally transcribed loci, as dis-
cussed in ref.19 In summary, bidirectionally transcribed
loci were defined from forwardand reverse strand CAGE
tag TCs supported by at least two CAGE tags in at least
one sample. Only TCs not overlapping antisense TCs
were used. We identified divergent (reverse–forward)
TC pairs separated by at most 400 bp and merged all
such pairs containing the same TC, while at the same
time avoiding overlapping forward and reverse strand
transcribed regions (prioritization by expression ranking).
A centre position was defined for each bidirectional
locus as the mid position between the rightmost
reverse strand TC and leftmost forward strand TC
included in the merged bidirectional pair. Each bidirec-
tional locus was further associated with two 200 bp
regions immediately flanking the centre position,
one (left) for reverse strand transcription and one
(right) for forward strand transcription, in a divergent
manner. The merged bidirectional pairs were further
required to be bidirectionally transcribed (CAGE tags
supporting both windows flanking the centre) in at
least one individual sample, and to have a greater ag-
gregate of reverse CAGE tags (over all samples) than
forward CAGE tags in the 200 bp region associated
with reverse strand transcription, and vice versa. We
quantified the expression of bidirectional loci for each
strandand200 bpflankingwindowineachsample sep-
arately by counting the CAGE tags whose 50 ends were
located within these windows. The expression values
of both flanking windows were normalized by convert-
ing tagcounts to TPM. The numberof CAGE tags aligned
to ChrM was subtracted from the total number of
aligned CAGE tags in each library before normalization.
The normalized expression values from both windows
were used to calculate a sample-set wide directionality
score,D, for each enhanceroveraggregated normalized
reverse,R, andforward,F, strandexpressionvaluesacross
all samples; D ¼ (F 2 R)/(F þ R). D ranges between 21
and 1 and specifies the bias in expression to reverse and
forward strand, respectively [D ¼ 0 means 50% reverse
and 50% forward strand expression, whereas abs(D)
close to 1 indicates unidirectional transcription]. Each
bidirectional locus was assigned one expression value
foreach sample bysumming the normalized expression
of the two flanking windows. Bidirectional loci were
further filtered to have low, non-promoter-like, direc-
tionality scores [abs(D) ,0.8] and to be located distant
to TSSs and exons of protein- and multi-exonic non-
coding genes. This set was used to extend the set of
CAGE-defined enhancers by the functional annotation
of mammalian genomes (FANTOM) consortium from a
large number of tissues and cells.19 The expression of
these enhancers were quantified in each individual
Caco-2 CAGE library as described above, and enhancers
supported by at least three CAGE tags in any Caco-2
library were considered for further analyses. Enhancers
with an absolute log2 expression fold change 2
between average TNF-a stimulated and unstimulated
samples were considered differentially expressed. Putative
enhancer–promoterassociationswere derived from prox-
imal enhancer–promoter pairs (within 200 kb) with
correlated expression (Pearson’s r .0.5).
2.6. Motif overrepresentation analysis
Regions 2300 to þ100 bp around the gene TSS (as
in ref.17) were scanned with all JASPAR29 motifs using
the Clover motif overrepresentation tool30 with
default settings, and all not-significantly regulated TCs
as background. When analysing TNF-responsive enhan-
cers, the regions +300 bp around the mid-positions
were used, using non-responsive enhancers as back-
ground.
2.7. qPCR validation of promoter usage
Total RNA from Caco-2 cells was extracted using
the NucleoSpin columns (Macherey-Nagel, Du¨ren,
Germany) following the manufacturer’s protocol. Total
RNA (1–2 mg) was used to prepare cDNA by SuperScript
III reversetranscriptase(Invitrogen,Paisley,UK)andquan-
titative real-time PCR (qPCR) reactions were performed
on a Stratagene Mx3000P thermocycler (Stratagene,
La Jolla, CA, USA) using the Maxima SYBR Green qPCR
Master Mix (Fisher Scientific, Pittsburgh, PA, USA) ac-
cording to manufacturer’s instructions. All primers were
purchased from Integrated DNA Technologies (Leuven,
Belgium). Primersweredesigned to amplify regions imme-
diately downstream of the CAGE signal (Supplementary
Table S1). Target gene expression values were normal-
ized to the RPLP0 gene, which was amplified in parallel
reactions.
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2.8. Transient transfection assays
One day prior to transfection, Caco-2 cells were
seeded in 24-well plates at a density of 5  104 cells/
well and transiently transfected the following day
as described previously.31 In stimulation experiments,
the medium was changed 24 h after transfection,
Figure 1. CAGE-defined promoters in Caco-2 cells. (A) Schematic illustration showing classification of CAGE-defined promoters based on
RefSeq annotation. The upper panel shows the number of CAGE tag clusters (TCs) mapping around an example gene loci (the CFLAR
gene) on the plus strand. The lower panel shows the RefSeq gene model exon–intron structure of the gene (blocks are exons, lines are
introns). CAGE peaks are commented as belonging to specific classes based on their location. CAGE tags falling outside of gene loci will
be classified as ‘novel intergenic’ (grey areas). Box labels indicate names used for respective classes in (B) and (C). RefSeq-annotated
alternative promoters that are not hit by CAGE are also indicated. (B) Distribution of Caco-2 TCs (TPM. 4) according to the TC classes
defined above using RefSeq annotation. (C) Distribution of Caco-2 TCs (TPM. 4) according to the TC classes defined above using
Gencode annotation. (D and E) Per cent of TCs falling into each of the classes from (B) and (C) split up by TNF-a response, using RefSeq
(D) or Gencode annotation (E). Bars shaded from black to light grey represent canonical, known alternative, novel intragenic and novel
intergenic TCs, respectively. Numbers above bars indicate the number of promoters in respective category.
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washed and subsequently stimulated with or without
TNF-a (10 nM) for the next 24 h. LAMC2 luciferase
reporter constructs were: pGL3-LAMC2 containing
the 1.2 kb LAMC2 promoter region upstream of TSS32
and pGL3-LAMC2 þ Enhancer containing the 1.2 kb
LAMC2 promoter and the enhancer region at
chr1:183,149,939–183,150,336 (hg19). The pGL3-
LAMC2 þ enhancerplasmidwasconstructedbyamplify-
ing the enhancer region by PCR and subcloning it into
pGL3-LAMC2 in the Sal1 site of pGL3-plasmid upstream
of the LAMC2promoter using the In-FusionwHD Cloning
kit from Clontech. For assays investigating the effect of
overexpression of NF-kB subunits on the LAMC2 tran-
scriptional activity, pCMV4-p65 and pCMV4-p50
(Addgene plasmid number: 21966 and 2196533) or
pCMV4-p52 (Addgene plasmid number: 2328934)
were used. Plasmids were co-transfected with the
LAMC2 reporter constructs. Forty-eight hours post-
transfection, cells were harvested and lysed; luciferase
and b-galactosidase activities were determined using
the Dual Light system (Perkin Elmer, Waltham, MA,
USA) according to manufacturer’s instructions.
3. Results
3.1. CAGE identifies novel TNF-a-responsive promoters
We prepared CAGE libraries from total RNA from
Caco-2 cells pre-treated with or without TNF-a in bio-
logical triplicates. CAGE tags were mapped to the
human genome, and nearby CAGE tags were grouped
into 52,451 TCs. As in previous work, we will for simpli-
city refer to theseTCsascandidate ‘promoters’.Usingan
expression cut-off of four TPM to focus on strong initi-
ation events, 13,970 TCs were retained, of which 92%
overlapped an annotated RefSeq gene model. The
remaining 8% were labelled novel intergenic promoter
candidates. A substantial fraction of genes (23%) had
two or more overlapping TCs on the same strand, sug-
gesting alternative initiation events that would not be
detected by, for example, microarray techniques. As in
the ENSEMBL annotation pipeline35 we defined the
canonical TSS as the TSS that is the most upstream
in annotated gene models. Of the TCs overlapping
RefSeq genes, 61% (7.814 TCs) were within 100 nt
from the canonical annotated TSS, while 7% (902 TCs)
Table 1. A list of the five most overrepresented GO terms in each GO category associated with the genes associated with differentially
regulated TCs found by CAGE in Caco-2 in response to the TNF-a stimulation
Genes linked to up-regulated TCs Genes linked to down-regulated TCs
Term P-value Adjusted P Term P-value Adjusted P
Biological process
Immune response 1.60E233 2.70E230 Nucleosome assembly 6.90E212 6.20E209
Defence response 3.60E222 3.10E219 Chromatin assembly 1.10E211 4.80E209
Response to wounding 1.30E217 7.60E215 Nucleosome organization 1.40E211 4.20E209
Inflammatory response 7.70E213 3.30E210 DNA packaging 1.50E211 3.30E209
Locomotory behaviour 1.20E212 4.10E210 Protein-DNA complex assembly 9.40E211 1.70E208
Cellular component
Extracellular region 5.50E219 1.10E216 Nucleosome 1.80E211 2.80E209
Extracellular region part 2.30E216 2.30E214 Preotein-DNA complex 3.00E209 2.40E207
Extracellular space 1.80E214 1.30E212 Chromosome 7.80E208 4.10E206
Intrinsic to plasma membrane 1.40E211 7.30E210 Chomosomal part 1.00E207 4.00E206
Integral to plasma 4.20E211 1.80E209 Chromatin 9.70E206 3.00E204
KEGG pathway
Cytokine-cytokine receptor interaction 3.70E234 3.90E232 Systemic lupus erythematosus 9.80E217 6.90E215
Pathways in cancer 1.70E218 8.80E217 Drug metabolism 3.10E204 9.70E203
Small cell lung cancer 3.20E213 1.10E211 Regulation of actin cytoskeleton 4.70E204 9.60E203
RIG-I like receptor signalling pathway 1.30E212 3.40E211 Glutathione metabolism 8.70E204 1.30E202
Chemokine signalling pathway 7.10E212 1.50E210 Cyanoamino acid metabolism 3.90E203 4.80E202
Molecular function
Cytokine activity 9.20E218 4.40E215 No GO terms with adjusted P, 0.05
Chemokine activity 8.70E210 2.10E207
Chemokine receptor binding 1.20E209 1.90E207
Growth factor activity 1.70E205 2.10E203
Cytokine binding 2.50E205 2.40E203
For details, see Materials and methods.
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Figure 2. Examples of CAGE-inferred promoters and their response to TNF-a stimulation. Each panel describes a validated gene locus: (A)
CFLAR, (B) NCK1, (C) PLD1, (D) the RP11-283G6.5 lncRNA, (E) novel putative lncRNA, (F) IFIH1 and a putative long distal promoter
of GCA. Each panel consists of three sub-panels: top, an UCSC browser43 overview of the gene landscape around the promoter(s) of
interest; middle, a zoom-in version of the above; bottom, qPCR validations of respective RNA isoforms emanating from the promoters of
interests as a function of TNF-a concentration. UCSC browser sub-panels show (when relevant and available) RefSeq genes, expressed
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were within 100 nt of annotated alternative promo-
ters, and the final 32% (4,101) did not overlap any
annotated TSS; we labelled these candidate novel alter-
native promoters (Fig. 1A and B). In order to compare
with a more comprehensive, but less conservative,
gene annotation, the same TCs were overlapped
with the Gencode V19 basic gene annotation.36 While
the number of TCs mapping to gene models and canon-
ical TSSs did not change substantially (94 and 53%,
respectively) compared with the RefSeq results, a larger
fraction of TCs within genes were overlapping Gencode-
annotated TSSs (25%), indicating that many of the intra-
genic TCs correspond to real mRNATSSs (Fig. 1C).
Next, we used EdgeR27 on the 13.970 TCs and identi-
fied 520 TCs with significant expression changes
between TNF-a stimulation and control (FDR ,0.05);
355 (68%) had a significant increase in expression
and 165 TCs had a significant decrease after stimula-
tion (Supplementary Table S2). We subsequently refer
to these two categories as TNF-a(þ) and TNF-a(2)
promoters/TCs.
RefSeq genes overlapping TNF-a(þ) promoters were
enriched in GO terms involving immune response,
defence and cytokine activity (Table 1). Many of the
TNF-a(þ) genes are well-studied responders to TNF-a
stimulation and/or inflammation including the
TNFAIP3,37 PTGS2,38 CFLAR,39 IL-8,40 HDAC941 and
SGPP242 genes. The TNF-a(2) genes include genes
associated with cell growth, including histone 1 genes.
In both TNF-a(þ) and TNF-a(2) sets, we observed a
remarkably high number of alternative promoters—
either novel or overlapping annotated cDNAs starting
within known genes; this is particularly true for
TNF-a(þ)promoters,where54% arenovel:143 corres-
pond to candidate alternative promoters within known
genes, and 49 correspond to novel intergenic promo-
ters (Fig. 1D and E).
To verify the findings, we randomly selected 18
TNF-a(þ) and 2 TNF-a(2) TCs within different
classes: known promoters, novel alternative promoters
and novel intergenic promoters. We validated their
response to TNF-a by qPCR in quadruplicates and four
different TNF-a concentrations. For validating alternative
promoters, we used two primer pairs: one pair located
immediately downstream of the TC of interest and the
other pair just downstream of the most upstream anno-
tated promoter. In the large majority (16 of 20) of
cases, the qPCR results validated the CAGE data as well
as the response to TNF-a (Fig. 2 and Supplementary
Figure S1). We highlight a few examples below; fold
changes and P-values refer to qPCR validations at
10 nM TNF-a, two-sided t-tests.
The first example is the CFLAR gene (Fig. 2A), a regu-
lator of apoptosis, known to be up-regulated in IECs
from patients with active UC.25 The mostupstream pro-
moter is only slightly TNF-a-responsive (1.3-fold in-
crease, P, 0.01), while the alternative promoter is
more responsive (3.6-fold, P, 0.001). Similarly, the
NCK1 gene, involved in signal transduction, has an
alternative promoter with a high up-regulation (170-
fold, P, 0.001) at the highest concentration of TNF-
a, while the response of the most upstream promoter
is less than two-fold (P, 0.01) (Fig. 2B). Thealternative
promoter is predicted to lead to loss of an SH3 domain,
described further below.
The PLD1 gene, a phospoholipase used in signal
transduction (Fig. 2C) and utilized by TNF-a to activate
the NF-kB and extracellular signal regulated kinase
(ERK1/2) during an immune response,44 has two pro-
moters defined byCAGE, where the annotatedmostup-
stream promoter is slightlyactivated by TNF-a (1.8-fold
increase P, 0.001), but the novel promoter found
30 kb downstream is down-regulated more than 4-
fold (P, 0.001) (Fig. 2C). This demonstrates that the
genes are not only up-regulated as a consequence of
TNF-a stimulation.
We also confirmed that two uncharacterized, long,
non-coding RNAs (lncRNAs) found by CAGE are
responding to TNF-a stimulation. The first (Fig. 2D),
annotated by GENCODE36 as RP11-283G6.5 extends
40 kb downstream to overlap the 30 UTR of the SSPN
gene on the antisense strand, is increased more than
60-fold in response to TNF-a (P, 0.001). Such chains
of linked sense–antisense RNAs have been previously
described45 and sense–antisense pairs have the poten-
tial to influence each other’s expression levels.46 The
other lncRNA (Fig. 2E) only has support from ENCODE
RNA-seq and ESTs, is situated in a large intergenic
region and is 50% down-regulated as a response to
TNF-a (P, 0.01). Since this lncRNA is functionally
uncharacterized, further experiments are needed to
deduce the impact of this down-regulation, but we
note that there is evidence for other lncRNAs with
direct functional roles in inflammation, such as the
LEHTE lncRNA which is induced by TNF-a, and binds
NF-kB in a negative feedback loop.47
Finally, we validated a TNF-a-responsive bidirectional
promoter composed of the annotated IFIH1 gene
sequenced tags (ESTs), GenCode36 annotation and mean normalized CAGE signal per nucleotide on relevant strand over three replicates.
Red and blue arrows indicate TSS clusters (core promoters) of interest and their direction of transcription. Sizes of arrows correspond to the
CAGE signal strength. Locations of qPCR primer pairs are shown in black, and in Supplementary Table S1. Respective examples are
commented in detail in the main text. For qPCR bar plots, the vertical axis shows the mean fold change vs. un-stimulated cells (four
replicates), error bars indicate standard error of mean. The red dotted line indicates a fold change of 1. The statistical significance (t-test)
is indicated above the bars: *P, 0.05, **P, 0.01, ***P, 0.001.
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(involved in interferon response and linked to auto-
immune diseases) and a paired novel promoter starting
on the opposite strand 200 bp upstream of the IFIH1
promoter (both promoters are.12-fold up-regulated,
P, 0.001) (Fig. 2F). GENCODE gene annotation36
shows that the novel promoter on the plus strand is
likely a distal promoter of the GCA gene, a regulator of
adhesion. We note that the canonical promoter of
GCA is expressed on similar levels before and after
TNF-a. Therefore, we hypothesize that usage of the bi-
directional promoter will make GCA partially respon-
sive to TNF-a.
3.2. Loss of protein domain-coding exons due to
alternative promoter usage
As discussed above, many of the responding TCs cor-
respond to known or novel alternative promoter candi-
dates. Related to this, 41 RefSeq gene models contained
two or more significantly responding TCs. In most of the
cases (36), all TCs within a gene were up-regulated,
in four cases both TCs were down-regulated and
in one case (TMEM150B) one TC was significantly
up-regulated while the other TC was significantly
down-regulated.
A handful of genes where the use of an alternative
promoter leads to exclusion of coding exons have
been described previously.48 One example is the pro-
moter usage in the LEF1 gene. This gene contains an
N-terminal domain necessary and sufficient to bind
b-catenin, a central domain that interacts with co-
repressors and a C-terminal DNA-binding domain.
The protein has two promoters: promoter 1 produces
full-length proteins which recruit b-catenin to Wnt
signalling, and promoter 2 produces proteins
lacking the b-catenin-binding domain and therefore
functions as repressors of Wnt signalling, hence the
two isoforms will have opposing effects. An imbal-
ance in the usage of these to promoters is, for
example, seen in colon cancer, where promoter 2 is
silenced.49
Our CAGE data make it possible to assess the fre-
quency of these types of events in Caco-2 as a response
to TNF-a. We found that 75 of the TNF-a(þ) promoters
arewithin an annotated coding region. These represent
shorter RNA isoforms, which, if translated, would give
rise to N-termini-truncated proteins. To identify cases
similar to the LEF1 example above, we investigated if
any of the intragenic TNF-a(þ) promoters were located
within or downstream of PFAM50 protein domains
mapped to the coding sequence. In total, we found 39
promoters in 33 genes, where usage of the TNF-a(þ)
promoter would lead to RNAs that exclude one or more
protein domains. Five of the promoters were within
100 bp from a known (alternative) RefSeq promoter,
where all the gene products are annotated as protein
coding. In these cases, it is likely that these TNF-a(þ)-
responsive promoters are producing proteins with trun-
cated N-termini and loss of functional domains. For
non-annotated alternative promoters, further validation
isneededtoprovethattheproducedRNAsare translated.
We here show four examples of genes where exons
containing domains are lost when using the TNF-a(þ)
promoters (Fig. 3).
The NCK1 gene, described and validated above
(Fig. 2B), have two promoters; the upstream P1 at the ca-
nonical promoter and P2, which is an alternative TSS and
preferentiallyusedafterTNF-atreatment.WhenusingP2,
oneoftheSH3_1domainsandoneoftheSH3_2domains
are lost (Fig. 3A). SH3 and SH2 domains are important for
protein–protein interaction, and the alternative pro-
moter usage could potentially lead to an up-regulation
of Ras activity in the cell.51
A more extreme example of loss of multiple domains
isCOL16A1 (qPCR validation showed in Supplementary
Figure S1G). This gene encodes the alpha chain of
type XVI collagen and maintains the integrity of the
extracellular matrix. COL16A1 contains several colla-
gen domains and usage of the alternative downstream
promoter decreases the number of collagen repeats
from 18 to 10 (Fig. 3B). This exemplifies a trend in
the dataset: if a domain is lost there is often (7 of 33
genes with alternative promoters analysed) another
instance of the domain still present in the resulting
transcript.
In some cases, usage of an alternative downstream
promoter leaves a transcript without predicted domains.
This is the case for the zinc finger protein TRIM29
(Fig. 3C). In the unstimulated state little transcription
is observed from this gene, but after stimulation we
observe high expression from an alternative promoter
situated approximately in the middle of the gene.
Using this promoter leads to loss of a B-box-type zinc
finger domain, often involved in ubiquitinylation, and
it is unclear whether the remaining transcript has any
function on protein level (Fig. 3C).
Another example of a gene where no downstream
domains are kept is the apoptotic regulator BCL2L13
(Fig. 3D). Most of the expression of this gene comes
from two distinct promoters, P1 at the annotated 50
end of the gene, and P2 mapping to an annotated
start site, which corresponds to an RNA including only
the last exon of the gene. In the unstimulated state P1
is primarily used. When stimulated the usage is
switched: P2 now shows the highest expression. When
P2 is used, the PFAM protein domain Bcl-2 is lost
(Fig. 3D). The shorter transcript, produced from P2,
has been described previously:52 overexpression of the
transcript resulted in higher activation of caspase-3
and apoptosis than the full-length variant. A necessary
caveat for these examples is that whereas CAGE data
might reveal whether a protein-coding domains is
lost due to alternative promoter usage, it cannot
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prove whether a certain alternative promoter pro-
duces a transcript that is translated into a protein,
in particular in cases where the alternative promoter
is not previously annotated and linked to sequenced
full-length RNAs.
3.3. Identification of enhancer candidates
responding to TNF-a
We have previously shown that bidirectional CAGE
TCs situated at most 200 nt from each other can iden-
tify enhancer RNA.19 The method has been extensively
validated with .100 in vitro reporter gene assays and
shown to be a more accurate prediction method for en-
hancer activity than untranscribed hypersensitive sites
or enhancer candidates predicted by chromatin immu-
noprecipitation.19 We have also shown that expression
correlations between the enhancer activity and that of
nearby promoters can identify physical interactions.
With the same approach as in ref.,19 using a combin-
ation of the CAGE data from this study supplemented
by CAGE data from a wide range of tissues,14,19 we
found 890 Caco-2-expressed candidate enhancers,
where 62% overlap Caco-2 DNase hypersensitive
sites20 (Supplementary Table S3). Of these, 443
(49.7%) responded 4-fold or more to stimulation by
TNF-a compared with control and 222 (of the 443)
were up-regulated as a response to TNF-a stimulation.
Within the list of 443 TNF-a-responsive enhancers, we
found 37 unique enhancer–promoter pairs with a
maximal distance of 200 kb, where the enhancer and
the promoter expression are highly correlated before
and after stimulation, suggesting regulatory inter-
action. An interestingexample of such pairings is theen-
hancer 60 kb downstream of the UBR4 gene,53 linked
by co-expression to a novel alternative promoter
within the UBR4 locus. We subsequently validated the
promoter expression change by qPCR (Fig. 4A). Other
examples include the TNF-a-induced candidate enhan-
cer region located within the first intron of theTNFSF10
gene—a member of the TNF ligand superfamily, whose
annotated promoter is also highly induced by TNF-a
(Fig. 4B), and an enhancer candidate 2 kb upstream of
the ANXA13 gene (known to increase in expression
during epithelial cell differentiation54) where both
the gene promoter and the enhancer expression is
decreased as a response to TNF-a (Fig. 4C).
Figure 3. Examples of loss of exons coding for protein domains due to alternative promoter usage. UCSC browser overview of the genes of
interest: (A) NCK1, (B) COL16A1, (C) TRIM29, (D) BCL2L13 similar to Fig. 2. From top; (i) bar graph of normalized CAGE tag counts
(TPM) from TNF-a(þ) and TNF-a(2). Only tags on the relevant strand are shown; (ii) Pfam domains mapped to UCSC genes and (iii)
RefSeq genes. Red and blue arrows indicate TSS clusters (core promoters) of interest and their direction of transcription. Sizes of arrows
correspond to the CAGE signal strength. Grey regions indicate the part of the gene that is retained by usage of alternative promoters of
interest. Lost, or partially lost, domains upstream of this region are highlighted in orange, while retained domains are highlighted in light
blue. Gene examples are commented in detail in the main text.
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3.4. Regulation of LAMC2 TNF-a response: an
example of CAGE-enabled targeted analysis
Computational prediction of transcription factor-
binding sites in promoter regions identified by CAGE
has proved to be a powerful approach for the id-
entification of key transcription factors in a given
system.6,10,16,17 Indeed, NF-kB-binding sites, and
binding sites of other known inflammatory transcrip-
tion factors such as SPIB (Table 2), are significantlyover-
represented in TNF-a(þ) promoters, which fits with
previous work.56
We were encouraged that the same transcription
factor-binding sites were also overrepresented in the
CAGE-defined enhancers activated by TNF-a (Table 3).
These sites were not overrepresented in TNF-a(2) pro-
moters and enhancers, which instead had an over-
representation of hepatocyte nuclear factor motifs
(HNF-4a and HNF-3a) (Tables 2 and 3). Since HNF-
4a is important for the differentiation of the IECs
during embryonic development, the overrepresenta-
tion of HNF-4a sites in the non-stimulated promoters
and enhancers could indicate that unstimulated cells
Figure 4. Examples of CAGE-inferred TNF-a responsive enhancers and their potential targets. Each panel consists of sub-panels: top, an UCSC
browser43 overview of the gene landscape around the enhancer and promoter of interest; bottom, zoom-in version(s) of the above. (A) An
enhancer is predicted downstream of theUBR4 gene identified by bidirectional CAGE tag pairs (left panel shows a zoom-in). It has support
frommultipledatatypes fromtheENCODEproject,21 includingChIP-seq for transcription factors, andhistonemarkstypicalof enhancers, as
well as Caco-2-specific DNase sensitivity site peaks. CAGE data are shown as in Fig. 2. The enhancer is induced by TNF-a, and is predicted to
interact with a CAGE-defined alternative promoter within the gene (middle panel), which is also induced by TNF-a (verified by qPCR as in
Fig. 2). Conversely, the annotated promoter is not responding highly to TNF-a (right panel). (B) A TNF-a-induced enhancer is predicted
within the first intron of the TNFSF10 gene, and predicted to interact with the annotated TSS, which also is highly TNF-a-induced. The
enhancer has support by ENCODE histone marks and multiple transcription factor ChIP peaks. (C) An enhancer, which is only used in
non-induced cells, is predicted 2 kb upstream of the annotated TSS of the ANXA13 gene, which also has much higher expression in the
non-induced state. The enhancer has support by multiple ENCODE transcription factor ChIP peaks. See main text for further discussion.
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are differentiating towards an IEC-like state57 while
differentiation is repressed in stimulated cells.
As a case example, we focused on the LAMC2 gene
(Fig. 5A) whose main promoter is.8-fold up-regulated
in TNF-a-stimulated Caco-2 cells as measured by CAGE.
LAMC2 has previously been shown to be induced
by TNF-a in other cell lines.58 Indeed, we validated
that TNF-a stimulation (P, 0.05, t-test) increased the
expression of LAMC2 mRNA and protein levels in a
dose-dependent manner with a maximal effect
observed at 10 nM (Fig. 5B and C). TNF-a can initiate
pro-inflammatory signalling by activating the NF-kB
pathway and the mitogen-activated protein kinase
(MAPK) pathway. In mammals there are three major
constituents of the MAPK superfamily: ERKs (ERK1/2
or p42/p44), c-Jun N-terminal kinases (JNK1/2/3)
and the p38 MAPK family.56 The NF-kB family of tran-
scription factors consists of five mammalian members
[NFKB1(p50), NFKB2(p52), RELA(p65) and RELB]59,60
that can form either homodimers or heterodimers.
Therefore, the role of these signalling pathways in TNF-
a-mediated up-regulation of endogenous LAMC2 ex-
pression in Caco-2 cells was investigated. Interestingly,
we noticed a 400 nt long candidate enhancer region
(chr1: 183,149,939–183,150,336, hg19 assembly)
upstream of the LAMC2 TSS, which is predicted to have
a single NF-kB-binding site and is also bound by RELA
as indicated by ENCODE ChIP-seq21 data (Fig. 5A).
Consistent with the hypothesis ofNF-kB-mediated regu-
lation, the NF-kB inhibitor TPCK effectively diminished
the effect of TNF-a on LAMC2 mRNA and protein levels
(Fig. 5E and F). Moreover, it has previously been demon-
stratedthatanactiveERKpathway is involvedintheregu-
lation of LAMC2 in squamous cell carcinoma.61
However, inhibition of ERK1/2 with FR180204 had
only a minor effect on the TNF-a-induced LAMC2
mRNA expression (Fig. 5D) and almost no effect on the
LAMC2 protein levels (Fig. 5F) in our experiments.
Since these findings indicate a transcriptional up-regula-
tion byTNF-aand NF-kB, we measuredthe effect ofTNF-
aonthe activityof anLAMC2promoterconstruct32 with
and without the predicted enhancer; the enhancerless
construct did not respond to TNF-a, but the enhan-
cer–promoterconstructgavea3-fold increase inreport-
er signal (P, 0.001 (t-test)) (Fig. 5G). Validating the
causal role of NF-kB, co-transfection of LAMC2 reporter
constructs with RELA in combination with NFKB1 or
NFKB2-expressionplasmidscouldsignificantly(P, 0.001
(t-test)) up-regulate the enhancer–promoter con-
struct but not the enhancerless construct. This effect
Table 2. Clover analysis of overrepresented transcription factor-
binding sites in the 2300 to þ100 bp region covering CAGE TCs
found in differentially expressed promoters of Caco-2, in response
to TNF-a stimulation
JASPAR motif Clover score Clover P-value Promoter response
RELA 245 ,0.001 TNF-a(þ)
NF-kappaB 214 ,0.001 TNF-a(þ)
REL 199 ,0.001 TNF-a(þ)
IRF1 198 ,0.001 TNF-a(þ)
SPIB 142 0.006 TNF-a(þ)
IRF2 135 ,0.001 TNF-a(þ)
dl_2 131 ,0.001 TNF-a(þ)
MZF1_1-4 131 ,0.001 TNF-a(þ)
ACE2 103 ,0.001 TNF-a(þ)
AP1 95.4 ,0.001 TNF-a(þ)
NFIC 41.7 ,0.001 TNF-a(2)
HAP4 38.8 0.002 TNF-a(2)
HAP3 37.5 0.007 TNF-a(2)
ACE2 32.3 0.001 TNF-a(2)
HNF4A 24.8 0.001 TNF-a(2)
nub 23.7 0.002 TNF-a(2)
SOK2 22.5 ,0.001 TNF-a(2)
FOXA1 21.6 0.001 TNF-a(2)
fkh 20.5 0.002 TNF-a(2)
sna 14 0.009 TNF-a(2)
P-values are calculated by Clover.55 Motif names are taken
from the JASPAR database.
Table 3. Clover analysis of overrepresented transcription factor-
binding sites in the 2300 to þ300 bp region around the centre
of CAGE-defined enhancers active in Caco-2, in response to TNF-a
stimulation
JASPAR motif Clover score Clover P-value Enhancer response
SPIB 114 0.008 TNF-a(þ)
AP1 87.3 ,0.001 TNF-a(þ)
RUNX1 57.1 ,0.001 TNF-a(þ)
NFE2L2 53.3 ,0.001 TNF-a(þ)
ARG81 53.2 0.001 TNF-a(þ)
HCM1 49.5 0.002 TNF-a(þ)
FOXI1 32.8 ,0.001 TNF-a(þ)
RELA 28.4 ,0.001 TNF-a(þ)
NF-kappaB 23.4 ,0.001 TNF-a(þ)
MET32 21.9 0.003 TNF-a(þ)
HNF4A 103 ,0.001 TNF-a(2)
EWSR1-FLI1 17.3 ,0.001 TNF-a(2)
Gata1 6.82 0.003 TNF-a(2)
NDT80 5.24 0.006 TNF-a(2)
CG15696 1.74 0.007 TNF-a(2)
En 0.827 0.009 TNF-a(2)
slou 0.742 0.004 TNF-a(2)
Hmx 0.513 0.001 TNF-a(2)
Unc-4 0.473 0.002 TNF-a(2)
tup 20.18 0.002 TNF-a(2)
P-values are calculated by Clover.55
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Figure 5. TNF-a regulates LAMC2 transcriptional activity by an NF-kB-bound enhancer. (A) An overview of the LAMC2 gene and its predicted
enhancer location upstream of the LAMC2 TSS. The RELA ChIP peak overlapping the predicted enhancer is taken from the ENCODE UCSC
ChIP track.21 Genome browser zoom-in shows CAGE data around the annotated TSS as shown in Fig. 2. (B) Dose-dependent increase of
LAMC2 mRNA expression in cells treated with increasing concentrations of TNF-a (0, 0.1, 1 or 10 nM). (C) Western blot analysis of
LAMC2 protein levels in TNF-a-treated cells and GAPDH used as an internal loading control. The shown blot represents three
independent experiments. The effect of (D) FR180204, an ERK inhibitor, and (E) TPCK, an NF-kB inhibitor, on the TNF-a-mediated up-
regulation of LAMC2 mRNA expression and (F) LAMC2 and GAPDH protein levels. Cells were pre-treated with inhibitors or with vehicle
DMSO (0.4%) for 1 h and then incubated with TNF-a (10 nM) for 24 h. (G) The effect of TNF-a and overexpression of NF-kB subunits on
the LAMC2 promoter activity with and without the enhancer shown in (A). Cells were transiently transfected with the human LAMC2
promoter (pGL3-LAMC2) (grey bars) or LAMC2 promoter/enhancer construct (pGL3-LAMC2 þ enhancer) (black bars) and were
unstimulated, stimulated with TNF-a for 24 h (black bars), co-transfected with plasmids overexpressing NFKB1(p50) and RELA NF-kB
subunits, or co-transfected with plasmids overexpressing NFKB2 and RELA NF-kB subunits. Asterisks indicate levels of significance:
*P, 0.05, **P, 0.01, ***P, 0.001 (t-test): error bars indicate the standard error of the mean.
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was highest in Caco-2 cells overexpressing both RELA
and NFKB2 subunits (P, 0.001) (Fig. 5G).
4. Discussion
Here, we have presented the first TSS map of the Caco-
2 cell line, and the changes in TSS usage as a response to
TNF-a. We show that almost half of the TNF-a-activated
promoters are novel, underscoring the importance of al-
ternativeandnovelpromoters inparticularandthemerit
of experimental methods not based on annotated genes.
Several of these have the potential to produce gene pro-
ducts that loose coding regions for important domains.
Regardless of whether the candidate promoters were
known, overlapped known genes or represented novel
transcripts, qPCR-based experiments could validate the
large majorityof the chosen promoters as TNF-a respon-
sive promoters (negative or positive).
CAGE has previously been used to locate active
enhancer regions and their putative gene targets,19
and its application to Caco-2 cells highlights a large
number of enhancer candidates, where many are
TNF-a-responsive. Interestingly, we observed that the
same type of transcription factor-binding sites were
overrepresented in both promoters and enhancer
regions that were activated as a response to TNF-a.
Related to this, a case study guided by the CAGE tech-
nique identified an NF-kB-responsive enhancer region
regulating the LAMC2 gene, which explains its respon-
siveness to TNF-a.62 LAMC2 has previously been
shown to be a useful biomarker in the diagnosis of
the invasiveness of cervical adenocarcinoma63 and in
colorectal cancer,64 but was here shown to be a poten-
tial inflammatory marker as well.
We have here presented comprehensive maps of the
locations and activity of promoters and enhancers in
the Caco-2 cell line. Importantly, many of the respond-
ing promoters are uncharacterized and comprise either
novel alternativepromoters (often tokey inflammatory
genes) or TSSs of uncharacterized RNAs that in all
likelihood are non-coding, which could not have been
detected by array-based methods. Therefore, our data are
a rich resource for empowering detailed, gene-centred
studies in Caco-2.
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